Burning Rock Biotech Limited (BNR)

Etorro trading 970x250

About Burning Rock Biotech Limited

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People’s Republic of China. The company primarily offers 13 next-generation sequencing-based cancer therapy selection tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoScreen Plus that targets therapy and immunotherapy, as well as immunotherapy- related biomarkers, such as microsatellite instability and tumor mutation burden, and NTRK fusions; and LungPlasma, a circulating tumor DNA liquid biopsy- based test for non-small cell lung cancer. It also offers ColonCore for testing gastrointestinal cancers; and HRDCore for testing genes associated with homologous recombination deficiency. Burning Rock Biotech Limited has collaborations on clinical trials and research studies with major pharmaceutical companies, including AstraZeneca, Bayer, Johnson & Johnson, Sino Biopharm, CStone Pharmaceuticals, and BeiGene primarily through central laboratory and companion diagnostics development services to pharmaceutical companies. The company was founded in 2014 and is headquartered in Guangzhou, China. Address: Building 3, Standard Industrial Unit 2, Guangzhou, China, 510005

Burning Rock Biotech Limited News and around…

Latest news about Burning Rock Biotech Limited (BNR) common stock and company :

Analysts Anticipate PGJ Will Reach $68
20 Oct, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Golden Dragon China ETF (PGJ), we found that the implied analyst target price for the ETF based upon its underlying holdings is $68.13 per unit.

Burning Rock Biotech Becomes Oversold (BNR)
15 Oct, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
06 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
05 Oct, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug
30 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
29 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA ...

12 Health Care Stocks Moving In Friday's After-Market Session
24 Sep, 2021 FinancialContent

Gainers eFFECTOR Therapeutics (NASDAQ:EFTR) stock rose 4.43% to $17.91 during Friday's after-market session. The ...

Look Under The Hood: PGJ Has 47% Upside
14 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Golden Dragon China ETF (PGJ), we found that the implied analyst target price for the ETF based upon its underlying holdings is $68.28 per unit.

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
01 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

Burning Rock Biotech Limited (BNR) Q2 2021 Earnings Call Transcript
31 Aug, 2021 FinancialContent

BNR earnings call for the period ending June 30, 2021.

The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
31 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Burning Rock Reports Second Quarter 2021 Financial Results
31 Aug, 2021 FinancialContent
The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week
29 Aug, 2021 FinancialContent

Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by ...

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
03 Aug, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Burning Rock and IMPACT Therapeutics Announce a Global Strategic Partnership for Companion Diagnostics Development
03 Aug, 2021 FinancialContent
Burning Rock Schedules Second Quarter of 2021 Earnings Release on August 31, 2021
02 Aug, 2021 FinancialContent
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
28 Jul, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...

74 Biggest Movers From Yesterday
27 Jul, 2021 FinancialContent

Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares jumped 109.7% to close at $8.87 on Monday after the company announced it entered ...

Burning Rock Biotech Enters Oversold Territory (BNR)
26 Jul, 2021 FinancialContent

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..

Calculating The Intrinsic Value Of Burning Rock Biotech Limited (NASDAQ:BNR)
26 Jul, 2021 Yahoo! Finance

Does the July share price for Burning Rock Biotech Limited ( NASDAQ:BNR ) reflect what it's really worth? Today, we...

Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021
14 Jul, 2021 FinancialContent

Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE:CMP) from Neutral to Buy. ...

Burning Rock Biotech (NASDAQ:BNR) Shareholders Booked A 19% Gain In The Last Year
11 Jun, 2021 Yahoo! Finance

On average, over time, stock markets tend to rise higher. This makes investing attractive. But not every stock you buy...

Burning Rock Biotech Limited (BNR) Q1 2021 Earnings Call Transcript
26 May, 2021 FinancialContent

BNR earnings call for the period ending March 31, 2021.

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal
25 May, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Burning Rock Biotech Ltd - ADR to Host Earnings Call
25 May, 2021 Yahoo! Finance

NEW YORK, NY / ACCESSWIRE / May 25, 2021 / Burning Rock Biotech Ltd - ADR (NASDAQ:BNR) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 25, 2021 at 8:00 AM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.

Earnings Scheduled For May 25, 2021
25 May, 2021 FinancialContent

Companies Reporting Before The Bell • Elbit Systems (NASDAQ:ESLT) is likely to report quarterly earnings at $1.40 per ...

Burning Rock Reports First Quarter 2021 Financial Results
25 May, 2021 FinancialContent
The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation
23 May, 2021 FinancialContent

Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, ...

Week In Review: LianBio Acquires Two IBD Candidates In $218 Million Deal
22 May, 2021 FinancialContent

LianBio, a Princeton-Shanghai company, in-licensed Greater China rights for two inflammatory bowel disease candidates from Landos Biopharma. The $218 million deal includes $18 million upfront and $200 million in milestones.

Burning Rock Biotech Scores Relative Strength Rating Upgrade; Hits Key Benchmark
21 May, 2021 FinancialContent

Burning Rock Biotech sees its Relative Strength Rating enter the 80-plus level.

Burning Rock Biotech Limited (BNR) is a NASDAQ Common Stock listed in , ,

970x250